The effect of metformin on androgen production in diabetic women with non-classic congenital adrenal hyperplasia

Experimental and Clinical Endocrinology and Diabetes

Volumn 122, Issue 10, 2014, Pages 568-571

  Krysiak, R ^a   Okopien, B ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

adrenal cortex; congenital adrenal hyperplasia; hormones; metformin

Indexed keywords

ANDROGEN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; HYDROXYPROGESTERONE; METFORMIN; PRASTERONE; TESTOSTERONE;

ADRENAL HYPERPLASIA, CONGENITAL; ADULT; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; MIDDLE AGED; TREATMENT OUTCOME;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; ANDROGENS; BLOOD GLUCOSE; DEHYDROEPIANDROSTERONE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERANDROGENISM; HYPOGLYCEMIC AGENTS; METFORMIN; MIDDLE AGED; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84939879947     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0034-1382048     Document Type: Article

References (23)

1. American Diabetes Association Standards of medical care in diabetes - 2013. Diabetes Care: 2013; 36 01 S11 S66
2. Genuth S. The UKPDS and its global impact. Diabet Med: 2008; 25 02 57 62
3. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med: 2002; 346 393 403
4. Scarpello J. H., Howlett H. C. Metformin therapy and clinical uses. Diab Vasc Dis Res: 2008; 5 157 167
5. Mahmood K., Naeem M., Rahimnajjad N. A. Metformin: the hidden chronicles of a magic drug. Eur J Intern Med: 2013; 24 20 26
6. Rachoń D. Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes: 2012; 120 205 209
7. Krysiak R., Okopień B., Gdula-Dymek A. et al. Update on the management of polycystic ovary syndrome. Pharmacol Rep: 2006; 58 614 625
8. Loverro G., Lorusso F., De Pergola G. et al. Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovary syndrome. Gynecol Endocrinol: 2002; 16 217 224
9. Diamanti-Kandarakis E., Kouli C., Tsianateli T. et al. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol: 1998; 138 269 274
10. Barba M., Schünemann H. J., Sperati F. et al. The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis. Clin Endocrinol (Oxf): 2009; 70 661 670
11. Banaszewska B., Pawelczyk L., Spaczynski R. Z. et al. Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment. J Clin Endocrinol Metab: 2011; 96 3493 3501
12. Banaszewska B., Pawelczyk L., Spaczynski R. Z. et al. Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial. J Clin Endocrinol Metab: 2009; 94 4938 4945
13. Auchus R. J. Congenital adrenal hyperplasia in adults. Curr Opin Endocrinol Diabetes Obes: 2010; 17 210 216
14. Speiser P. W. Nonclassic adrenal hyperplasia. Rev Endocr Metab Disord: 2009; 10 77 82
15. Moran C., Azziz R. 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender. Semin Reprod Med: 2003; 21 295 300
16. Banaszewska B., Pawelczyk L., Spaczynski R. Z. et al. Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial. J Clin Endocrinol Metab: 2007; 92 456 461
17. Sathyapalan T., Kilpatrick E. S., Coady A. M. et al. The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study. J Clin Endocrinol Metab: 2009; 94 103 108
18. Kaya C., Pabuccu R., Cengiz S. D. et al. Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: a prospective, randomized study. Exp Clin Endocrinol Diabetes: 2010; 118 161 166
19. Krysiak R., Okopien B. The effect of simvastatin treatment on plasma steroid levels in females with non-classic congenital adrenal hyperplasia. Exp Clin Endocrinol Diabetes: 2013; 121 643 646
20. Mapas-Dimaya A. C., Agdere L., Bahtiyar G. et al. Metformin-responsive classic salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a case report. Endocr Pract: 2008; 14 889 891
21. Miller W. L. Steroidogenic enzymes. Endocr Dev: 2008; 13 1 18
22. Mansfield R., Galea R., Brincat M. et al. Metformin has direct effects on human ovarian steroidogenesis. Fertil Steril: 2003; 79 956 962
23. Tosca L., Solnais P., Ferré P. et al. Metformin-induced stimulation of adenosine 5′ monophosphate-activated protein kinase (PRKA) impairs progesterone secretion in rat granulosa cells. Biol Reprod: 2006; 75 342 351